Evidence map›Paper›PMID 24055458›Full record

ArticleJournal of structural biology2013

Atomic force microscopy studies of APOBEC3G oligomerization and dynamics.

Luda S Shlyakhtenko, Alexander Y Lushnikov, Atsushi Miyagi, Ming Li, Reuben S Harris, Yuri L Lyubchenko

Open access · greenAbstract read
In one paragraph

Article in Journal of structural biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Functional requirements of AID's higher order structures and their interaction with RNA-binding proteins.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Luda S ShlyakhtenkoDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE 68198-6025, United States.
Alexander Y Lushnikov
Atsushi Miyagi
Ming Li
Reuben S Harris
Yuri L Lyubchenko
University of Nebraska Medical Center · USUniversity of Minnesota · US

Funding

Structural Characterization of APOBECS's Atomic interactionsP01GM091743 · NIGMS · UNIVERSITY OF MINNESOTA · PI KOTLER, MOSHE · 2011 to 2015
$10.1M
Mechanistic studies of stalled DNA replication fork rescueR01GM100156 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BIANCO, PIERO R, LYUBCHENKO, YURI L · 2013 to 2021
$4.0M
Protein Self-Assembly into NanoaggregatesR01GM096039 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LYUBCHENKO, YURI L · 2011 to 2018
$2.9M
Bioscope II - AFM system for Nanoimaging Core FacilityS10RR023400 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LYUBCHENKO, YURI L · 2007 to 2007
$369k
NCRR NIH HHS S10 RR023400NIGMS NIH HHS 1P01GM091743-02NIGMS NIH HHS 1R01GM100156-01A1NIGMS NIH HHS 3R01GM096039-02NIGMS NIH HHS P01 GM091743NIGMS NIH HHS R01 GM096039NIGMS NIH HHS R01 GM100156
6 · The paper itself

Abstract

The DNA cytosine deaminase APOBEC3G (A3G) is a two-domain protein that binds single-stranded DNA (ssDNA) largely through its N-terminal domain and catalyzes deamination using its C-terminal domain. A3G is considered an innate immune effector protein, with a natural capacity to block the replication of retroviruses such as HIV and retrotransposons. However, knowledge about its biophysical properties and mechanism of interaction with DNA are still limited. Oligomerization is one of these unclear issues. What is the stoichiometry of the free protein? What are the factors defining the oligomeric state of the protein? How does the protein oligomerization change upon DNA binding? How stable are protein oligomers? We address these questions here using atomic force microscopy (AFM) to directly image A3G protein in a free-state and in complexes with DNA, and using time-lapse AFM imaging to characterize the dynamics of A3G oligomers. We found that the formation of oligomers is an inherent property of A3G and that the yield of oligomers depends on the protein concentration. Oligomerization of A3G in complexes with ssDNA follows a similar pattern: the higher the protein concentrations the larger oligomers sizes. The specificity of A3G binding to ssDNA does not depend on stoichiometry. The binding of large A3G oligomers requires a longer ssDNA substrate; therefore, much smaller oligomers form complexes with short ssDNA. A3G oligomers dissociate spontaneously into monomers and this process primarily occurs through a monomer dissociation pathway.

Indexed as

APOBEC-3G DeaminaseCytidine DeaminaseDNA, Single-StrandedHEK293 CellsHumansMicroscopy, Atomic ForceParticle SizeProtein BindingProtein MultimerizationTime-Lapse ImagingAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseDNA, Single-StrandedA3GAFMaminopropyl silatrane treated micaAPOBECAPOBEC3Gapolipoprotein B mRNA editing enzyme, catalytic polypeptide-likeAPS-micaatomic force microscopyAtomic force microscopyHigh-speed AFMsingle-stranded DNASingle-stranded DNA binding proteinsSite search mechanismsssDNA

Identifiers

PMID24055458
PMCPMC3844295
OpenAlexW2003108516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.